Condition
Ocular Graft Versus Host Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Ocular Graft Versus Host Disease clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Australia (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
d-MAPPS Ophthalmic Solution for adults with chronic oGVHD
This Phase 3 trial tests whether d-MAPPS ophthalmic drops can help adults with chronic ocular graft-versus-host disease compared with a placebo-like vehicle over 90 days.
-
Phase II randomized double-masked crossover test of rhPRG4 (450 µg/mL) eye drops versus vehicle for ocular GVHD dry eye
This 84-day crossover study will try rhPRG4 eye drops versus a vehicle drop in adults with moderate to severe ocular graft‑versus‑host disease to see if eye symptoms and corneal staining get better.
Quick answers
How many Ocular Graft Versus Host Disease clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.